Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (6): 590-594,599    DOI: 10.19485/j.cnki.issn2096-5087.2022.06.009
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
墨玉县成年人群血脂异常调查
杨娟1, 李肖晓2, 程蕊蕊1, 诸葛瑾慧2, 吾孜木·吉格尔1, 姚华2, 张明琛3
1.新疆医科大学第一附属医院内分泌与代谢病科,新疆 乌鲁木齐 830011;
2.新疆医科大学,新疆 乌鲁木齐 830000;
3.中国科学院大学宁波华美医院,浙江 宁波 315153
Prevalence of dyslipidemia among adults in Moyu County
YANG Juan1, LI Xiaoxiao2, CHENG Ruirui1, ZHUGE Jinhui2, Wuzimu Jigeer1, YAO Hua2, ZHANG Mingchen3
1. Department of Endocrinology and Metabolic Diseases, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China;
2. Xinjiang Medical University, Urumqi, Xinjiang 830000, China;
3. Ningbo Hwa-Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315153, China
全文: PDF(836 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解新疆维吾尔自治区和田地区墨玉县成年人群血脂异常的流行情况,为预防和控制血脂异常提供依据。方法 收集2018—2019年墨玉县≥18岁常住居民健康体检资料,包括人口学信息、身高、体重、血压和血生化指标检测结果等;描述性分析居民血脂异常流行特征。结果 调查166 142人,年龄为(41.08±15.72)岁;男性77 744人,占46.76%;肥胖34 728例,占20.90%;糖尿病5 776例,占3.48%;高血压26 294例,占15.83%。三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)水平分别为(1.38±0.98)、(4.13±1.19)、(1.31±0.41)和(2.25±0.77)mmol/L。检出血脂异常49 373例,检出率为29.72%,其中高TG血症、高TC血症、低HDL-C血症和高LDL-C血症检出率分别为9.73%、4.59%、19.65%和1.99%。男性血脂异常检出率为33.97%,高于女性的25.98%(χ2=1 264.729,P<0.001)。随年龄、体质指数增加,血脂异常检出率呈上升趋势(χ2趋势=539.382、3 601.833,均P<0.001)。高血压和糖尿病患者血脂异常检出率均较高(χ2=497.251、766.142,均P<0.001),分别为35.48%和46.07%。有2项及以上血脂指标异常9 059例,占18.35%;肥胖、高血压、糖尿病患者中有2项及以上血脂指标异常分别占26.50%、24.14%和33.15%。结论 墨玉县成年人群血脂异常检出率低于全国水平,以低HDL-C血症最常见。肥胖、高血压和糖尿病患者的血脂异常患病率较高且同时合并多项血脂指标异常。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 血脂异常肥胖糖尿病高血压    
AbstractObjective To investigate the prevalence of dyslipidemia among adults in Moyu County, Hotan Prefecture, Xinjiang Uygur Autonomous Region, so as to provide insights into the management of dyslipidemia. Methods The physical examination data of permanent residents at ages of 18 years and older were collected from Moyu County from 2018 to 2019, including demographic features, height, body weight, blood pressure and blood biochemical parameter measurements. The epidemiological characteristics of dyslipidemia were analyzed among residents. Results Totally 166 142 adults were investigated, with a mean age of (41.08±15.72) years. There were 77 744 men (46.76%), 34 728 obese adults (20.90%), 5 776 adults with diabetes (3.48%) and 26 294 adults with hypertension (15.83%). The levels of triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were (1.38±0.98), (4.13±1.19), (1.31±0.41) and (2.25±0.77) mmol/L, respectively. The prevalence of dyslipidemia was 29.72%, and the detection rates of high TG, high TC, low-HDL-C and high LDL-C were 9.73%, 4.59%, 19.65% and 1.99%, respectively. The prevalence of dyslipidemia was higher in men than in women (33.97% vs. 25.98%; χ2=1 264.729, P<0.001), and the prevalence increased with age (χ2=539.382, P<0.001) and body mass index (χ2=3 601.833, P<0.001). The prevalence of dyslipidemia was 35.48% among patients with hypertension (χ2=497.251, P<0.001) and 46.07% among patients with diabetes (χ2=766.142, P<0.001). There were 9 059 adults with two and more abnormal blood lipid indexes (18.35%), and the detection rates of two and more abnormal blood lipid indexes were 26.50%, 24.14% and 33.15% among patients with obesity, hypertension and diabetes, respectively. Conclusions The prevalence of dyslipidemia among adults in Moyu County is lower than the national level, and low-HDL cholesterolemia is the most common type of dyslipidemia. The prevalence of dyslipidemia is high among patients with obesity, hypertension and diabetes mellitus, in whom abnormality of multiple blood lipid indexes is measured.
Key wordsdyslipidemia    obesity    diabetes    hypertention
收稿日期: 2021-11-22      修回日期: 2022-03-04      出版日期: 2022-06-10
中图分类号:  R587.1  
基金资助:国家自然科学基金(81760161)
作者简介: 杨娟,硕士,医师,主要从事内分泌与代谢性疾病研究
通信作者: 张明琛,E-mail:zhangmc1015@163.com   
引用本文:   
杨娟, 李肖晓, 程蕊蕊, 诸葛瑾慧, 吾孜木·吉格尔, 姚华, 张明琛. 墨玉县成年人群血脂异常调查[J]. 预防医学, 2022, 34(6): 590-594,599.
YANG Juan, LI Xiaoxiao, CHENG Ruirui, ZHUGE Jinhui, Wuzimu Jigeer, YAO Hua, ZHANG Mingchen. Prevalence of dyslipidemia among adults in Moyu County. Preventive Medicine, 2022, 34(6): 590-594,599.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.06.009      或      http://www.zjyfyxzz.com/CN/Y2022/V34/I6/590
[1] PIKULA A,BEISER A S,WANG J,et al.Lipid and lipoprotein measurements and the risk of ischemic vascular events:Framingham Study[J].Neurology,2015,84(5):472-479.
[2] 李苏宁,张林峰,王馨,等.2012—2015年我国≥35岁人群血脂异常状况调查[J].中国循环杂志,2019,34(7):681-687.
LI S N,ZHANG L F,WANG X,et al.Status of dyslipidemia among adults aged 35 years and above in China[J].Chin Circ J,2019,34(7):681-687.
[3] 王岩,王应昉,陈凤,等.铁西区老年人血脂异常及影响因素分析[J].预防医学,2020,32(9):920-922.
WANG Y,WANG Y F,CHEN F,et al.Prevalence and influencing factors of dyslipidemia among the elderly in Tiexi District[J].Prev Med,2020,32(9):920-922.
[4] 李文丽,苏银霞,诸葛瑾慧,等.新源县哈萨克族人群主要慢性病的影响因素分析[J].预防医学,2021,33(4):398-403.
LI W L,SU Y X,ZHUGE J H,et al.Prevalence and influencing factors of chronic diseases among Kazakh ethnic group in Xinyuan County[J].Prev Med,33(4):398-403.
[5] 井丽,张博强,田园梦,等.辽宁省40岁及以上农村居民血脂异常及影响因素分析[J].预防医学,2020,32(5):449-454.
JING L,ZHANG B Q,TIAN Y M,et al.Prevalence of dyslipidemia and its influencing factors in rural residents aged 40 years and over in Liaoning Province[J].Prev Med,2020,32(5):449-454.
[6] 李亚鹏,丁玉松,马儒林,等.新疆维吾尔族成人血脂异常及其影响因素分析[J].中华内分泌代谢杂志,2013,29(8):690-692.
LI Y P,DING Y S,MA R L,et al.Distribution and influencing factors of dyslipidemia in Uygur adults[J].Chin J Endocrinol Metab,2013,29(8):690-692.
[7] 戴璟,闵杰青,杨云娟.中国九省市成年人血脂异常流行特点研究[J].中华心血管病杂志,2018,31(2):114-118.
DAI J,MIN J Q,YANG Y J.A study on the epidemic characteristics of dyslipidemia in adults of nine provinces of China[J].Chin J Cardiol,2018,31(2):114-118.
[8] XUE M,LIU L,WANG S,et al.A simple nomogram score for screening patients with type 2 diabetes to detect those with hypertension:a cross-sectional study based on a large community survey in China[J/OL].PLoS One,2020,15(8)[2022-03-04].https://doi.org/10.1371/journal.pone.0236957.
[9] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.
Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia in Adults.2016 Chinese guideline for the management of dyslipidemia in adults[J]. Chin Circ J,2016,31(10):937-953.
[10] 中华人民共和国卫生部.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.
Ministry of Health of the People's Republic of China.Guidelines for the prevention and control of overweight and obesity in adults in China[M]the prevention and control of overweight and obesity in adults inChina[M].Beijing:People's Medical Publishing House,2006.
[11] 隋辉,王文.《中国高血压基层管理指南》(2014年修订版)要点解读[J].临床荟萃,2015,30(7):721-724.
[1] 张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[2] 王梦琴, 柴荟琳, 郭宇燕, 任敬娟, 梁瑞峰. 山西省农村居民高血压防治知识、态度、行为调查[J]. 预防医学, 2023, 35(7): 563-569.
[3] 张丹平, 徐玲妙. 糖尿病与血管性痴呆发病的关联、病理机制及防治策略研究[J]. 预防医学, 2023, 35(7): 582-586.
[4] 柏旭, 苏洁, 李凤, 徐倩, 沈源, 肖凌凤. 我国成人糖尿病视网膜病变影响因素的Meta分析[J]. 预防医学, 2023, 35(7): 595-601.
[5] 聂东梅, 李一鹏, 黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学, 2023, 35(7): 602-606.
[6] 沈益妹, 章奇, 朱新凤, 丁晶莹, 俞梅华. 湖州市血压控制未达标高血压患者慢性病共病及影响因素分析[J]. 预防医学, 2023, 35(6): 541-545,550.
[7] 丁承辉, 吴萃, 薛琨, 励晓红, 万金豹, 陈秋艳, 朱潇翔. 宝山区糖尿病高危人群筛查结果分析[J]. 预防医学, 2023, 35(6): 509-513.
[8] 沈放如, 杨可, 刘厚璞, 朱家豪, 李迎君. 新生儿出生体重与母亲2型糖尿病关联的双向孟德尔随机化研究[J]. 预防医学, 2023, 35(5): 384-387,409.
[9] 马奕竹, 赵效国, 朱启英, 马依拉·买买提, 张环美, 苑晓琳, 李莉. 孕期膳食模式与妊娠糖尿病的关联研究[J]. 预防医学, 2023, 35(4): 286-290.
[10] 张红, 胡志明, 潘晓锋, 朱梦胜, 戴伟丽, 谢伊丽, 诸建方. 社区高血压患者Triangle分层分级管理效果评价[J]. 预防医学, 2023, 35(4): 350-354,358.
[11] 刘国志, 袁空军, 庄蔚, 周光清. 国内外城市社区2型糖尿病健康管理模式比较[J]. 预防医学, 2023, 35(3): 262-266.
[12] 顾逸藜, 孙晓燕, 谢臻蔚. 女性糖尿病与压力性尿失禁研究进展[J]. 预防医学, 2023, 35(2): 130-133.
[13] 谢睿, 胡菊莲, 喻喆. 妊娠糖尿病患者生活质量的影响因素研究[J]. 预防医学, 2023, 35(2): 162-165.
[14] 杨洋, 何田静, 祝淑珍, 张岚, 黄希宝. 成年人群睡眠与肥胖的关联研究[J]. 预防医学, 2023, 35(2): 116-120.
[15] 王晓薇, 许艳岚. 老年2型糖尿病患者认知衰弱风险预测研究[J]. 预防医学, 2023, 35(12): 1037-1042.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed